Cited by 560Bone Metabolism and DiseasesBone health and osteoporosis researchOsteomyelitis and Bone Disorders Research

Coupling of bone resorption and formation by RANKL reverse signalling

Ikebuchi, Yuki, Aoki, Shigeki, Honma, Masashi, Hayashi, Madoka, Sugamori, Yasutaka, Khan, Masud, Kariya, Yoshiaki, Kato, Genki +5 more·2018·Nature

Abstract

Receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) binds RANK on the surface of osteoclast precursors to trigger osteoclastogenesis. Recent studies have indicated that osteocytic RANKL has an important role in osteoclastogenesis during bone remodelling; however, the role of osteoblastic RANKL remains unclear. Here we show that vesicular RANK, which is secreted from the maturing osteoclasts, binds osteoblastic RANKL and promotes bone formation by triggering RANKL reverse signalling, which activates Runt-related transcription factor 2 (Runx2). The proline-rich motif in the RANKL cytoplasmic tail is required for reverse signalling, and a RANKL(Pro29Ala) point mutation reduces activation of the reverse signalling pathway. The coupling of bone resorption and formation is disrupted in RANKL(Pro29Ala) mutant mice, indicating that osteoblastic RANKL functions as a coupling signal acceptor that recognizes vesicular RANK. RANKL reverse signalling is therefore a potential pharmacological target for avoiding the reduced bone formation associated with inhibition of osteoclastogenesis.

Integrity signals

Registry

Crossref · 10.1038/s41586-018-0482-7

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vesicular RANK binds to RANKL on the osteoblast surface and triggers mTOR-dependent stimulation of Runx2.

    “However, a recent study demonstrated that vesicular RANK binds to RANKL on the osteoblast surface (and possibly on osteocytes) and triggers the mTOR-dependent stimulation of Runx2238 (Fig. 5).”
  • Actively resorbing osteoclasts promote differentiation of neighboring osteoblast precursors into mature bone-forming cells.

    “This finding suggests a previously unknown scenario in which actively resorbing osteoclasts promote the differentiation of neighboring osteoblast precursors into mature bone-forming cells.”
  • RANKL monomers expressed on osteoblasts are not activated by RANK or by OPG, as indicated by deletion of RANK or OPG failing to reduce bone formation.

    “RANKL monomers expressed on osteoblasts are not activated by RANK238 or by OPG, as indicated by the deletion of RANK or OPG failing to reduce bone formation.245”
  • Osteoblasts do not efficiently deposit bone ECM when RANKL reverse signaling is suppressed.

    “The physiological importance of the messages shuttled by EVs has been confirmed by the observation that osteoblasts do not efficiently deposit bone ECM when RANKL reverse signaling is suppressed.238”
  • RANKL clustering on early osteoblasts may be required for activation of RANKL reverse signaling in resorption lacunae.

    “RANKL clustering on early osteoblasts may therefore be required for the activation of RANKL reverse signaling in resorption lacunae, similar to the effect of shuttling RANK in osteoclast EVs during bone remodeling (Fig. 5) or that of an anti-RANKL antibody-containing leucine zippers, which induce trimer formation.238”

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ikebuchi, Y., Aoki, S., Honma, M., Hayashi, M., Sugamori, Y., Khan, M., Kariya, Y., Kato, G., Tabata, Y., Penninger, J. M., Udagawa, N., Aoki, K., & Suzuki, H.
Affiliations
  • University of Tokyo Hospital (JP)
  • Tokyo Medical and Dental University (JP)
  • Kyoto University (JP)
  • Institute of Molecular Biotechnology (AT)
  • Matsumoto Dental University (JP)
Corresponding author
Honma, Masashi
Venue
Nature
Published
2018-09-05
Volume
561
Issue
7722
Pages
195-200
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2890611509
Cited by
557
References
35
Citations by year
2026: 37 · 2025: 71 · 2024: 85 · 2023: 63 · 2022: 75 · 2021: 78 · 2020: 83 · 2019: 53 · 2018: 12
FWCI
20.10
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
Japan Society for the Promotion of Science (17K19776, 16K11818, 18H02918, 16H05445, 17F17124, 18K04734, 16K20419, 16H06261, 16H05508)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords
RANK, osteoclasts, osteoblasts, bone resorption, bone formation, bone remodeling, Runx2, proline-rich motif, osteoclastogenesis
MeSH terms
Animals, Bone Resorption, Cell Differentiation, Cross-Linking Reagents, Female, Male, Mice, Inbred C57BL, Osteoblasts, Osteoclasts, Osteogenesis, Signal Transduction, Amino Acid Substitution, Cytoplasmic Vesicles, Core Binding Factor Alpha 1 Subunit, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review